Study of XL228 in Subjects With Chronic Myeloid Leukemia or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia

NCT00464113 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

49

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Chronic Myeloid Leukemia
Leukemia, Lymphoblastic, Acute, Philadelphia-Positive

Interventions

DRUG: XL228

Sponsor

Exelixis